PDF Ebook about: Pharmacokinetics

Pharmacokinetics

List of ebooks and manuals about Pharmacokinetics

24 documents available in our comprehensive collection of Pharmacokinetics resources. Find practical guides, tutorials, and documentation to enhance your knowledge.

Preview of Green Version
PDF file

Green Version (1996.full.pdf)

603 KBEN 8 pages
Lipidots, synthetic lipid nanoparticles, were characterized for in vivo stability, biodistribution, and pharmacokinetics
Preview of Buprenorphine Guide
PDF file

Buprenorphine Guide (3-Pharmacology.pdf)

3.21 MBEN 59 pages
Buprenorphine training covers pharmacology, opioid categories, receptors, classification, tolerance, withdrawal, and buprenorphine pharmacokinetics, including
Preview of > Impact of dosing method to PK whitepaper
PDF file

> Impact of dosing method to PK whitepaper (CS22-1f.pdf)

142 KBnrobinosEN 6 pages
Accurate evaluation of a new compound's pharmacokinetic (PK) and pharmacodynamic (PD) profile is essential in the drug development process.
Preview of Galen Award Holders
PDF file

Galen Award Holders (Galen-Award-holders.pdf)

277 KBEN 4 pages
Emma Davies (Trends in Opioid Prescribing and Associated resource utilisation in Wales), Haifa Lyster (altered pharmacokinetic profiles to commonly used...
Preview of FDA.gov, Synercid Data Sheet
PDF file

FDA.gov, Synercid Data Sheet (050748s008050747s008lbl.pdf)

446 KBEN 16 pages
Synercid is a streptogramin antibacterial agent for intravenous administration, approved for treating serious or life-threatening infections associated with...
Preview of Population Pharmacokinetic and Exposure-Response Analysis of Linagliptin in Pediatric Patients with Type 2 Diabetes Mellitus
PDF file

Population Pharmacokinetic and Exposure-Response Analysis of Linagliptin in Pediatric Patients with Type 2 Diabetes Mellitus (ACoP14_M-035_Population-Pharmacokinetic-and-Exposure-Response-Analysis-of-Linagliptin-in-Pediatric-Patients-with-Type-2-Diabetes-Mellitus.pdf)

330 KBEN 1 page
Linagliptin, a DPP-4 inhibitor, was evaluated in pediatric patients with type 2 diabetes mellitus (T2DM) in a 26-week trial with a 52-week safety extension.
Preview of List item Lynparza-H-C-3726-X-0016-G : EPAR - Assessment Report - Extension (PDF/3.33 MB) AdoptedFirst published: 28/05/2018 Las
PDF file

List item Lynparza-H-C-3726-X-0016-G : EPAR - Assessment Report - Extension (PDF/3.33 MB) AdoptedFirst published: 28/05/2018 Las (lynparza-h-c-3726-x-0016-g-epar-assessment-report-extension_en.pdf)

3.33 MBCHMPEN 163 pages
The European Medicines Agency (EMA) issued an assessment report on the extension of marketing authorisation for Lynparza (olaparib) on February 22, 2018.
Preview of Download pdf
PDF file

Download pdf (Stat-Nat-Custom-Freeze-Drying-300dpi_1page_leg.pdf)

490 KBEN 1 page
Master Mix for versatile molecular diagnostics, covering DNA, RNA, and parasitology with stabilized amplification technology. Includes pharmacogenetics markers (TPMT, CYP2C9, etc.), malaria screening, virology (HIV, CMV), respiratory pathogens (MTBC), and healthcare-associated...
PDF
PREVIEW
NOT
AVAILABLE
PDF file

Androgen Receptor Inhibition (AUA-2020_poster_final.pdf)

11.66 MBEN 1 page
EPI-7386 is a new N-terminal domain androgen receptor inhibitor for treating prostate cancer, showing preclinical efficacy, selectivity, and safety, with a...
Preview of Electives for Fall 2023
PDF file

Electives for Fall 2023 (Fall-2023-Electives_Revised.pdf)

307 KBCicely ANN HemphillEN 5 pages
Students must complete 11 credit hours of electives by the end of the P3 Spring year.
Preview of https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021153s022lbl.pdf
PDF file

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021153s022lbl.pdf (021153s022lbl.pdf)

593 KBEN 22 pages
NEXIUM (esomeprazole magnesium) Delayed-Release Capsules contain the active ingredient...
Preview of biomedicines-11-02287
PDF file

biomedicines-11-02287 (biomedicines-11-02287.pdf)

6.76 MBPeter I. Parry, Astrid Lefringhausen, Conny Turni, Christopher J. Neil, Robyn Cosford, Nicholas J. HEN 50 pages
Researchers found that the COVID-19 spike protein, whether from the SARS-CoV-2 virus or produced by vaccine gene codes, is pathogenic and can cause harm,...
Preview of Oncology Clinical Trials
PDF file

Oncology Clinical Trials (FDA-Guidelines-AdoInAdultTrial.pdf)

164 KBFDA/CDER/MCCRAYKEN 7 pages
The FDA guidance considers the inclusion of adolescent patients (ages 12-17) in adult oncology clinical trials, recommending their inclusion in disease- and...
Preview of SMA Therapeutics
PDF file

SMA Therapeutics (4acd6a_b94333b61aa3469d9975be9998bf32c2.pdf)

544 KBBhavya Ravi, Michelle Harran Chan-Cortés, Charlotte J. SumnerEN 17 pages
Spinal muscular atrophy (SMA) has seen significant progress with three FDA-approved treatments: nusinersen, onasemnogene abeparvovec, and risdiplam, which...
Preview of Cerebyx Label
PDF file

Cerebyx Label (020450s020lbl.pdf)

304 KBfda/cderEN 23 pages
CEREBYX (fosphenytoin sodium injection) is a prodrug of phenytoin, with 1.5 mg of fosphenytoin sodium equivalent to 1 mg of phenytoin sodium.
Preview of Celexa Warning
PDF file

Celexa Warning (020822s045lbl.pdf)

579 KBfda/cderEN 37 pages
Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults; Celexa is not approved for use in pediatric...
Preview of Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J. Invasive pulmonary aspergillosis complicating severe i
PDF file

Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J. Invasive pulmonary aspergillosis complicating severe i (Vanderbreke2018EpidemiologyAspergillosisInfluenza.pdf)

202 KBEN 10 pages
Invasive pulmonary aspergillosis (IPA) is a frequent and severe complication of severe influenza, with high morbidity and mortality.
Preview of First-in-Human Study of MT-6402, a PD-L1 Targeting Engineered Toxin Body, in Patients with Relapsed or Refractory Advanced Solid Tumors
PDF file

First-in-Human Study of MT-6402, a PD-L1 Targeting Engineered Toxin Body, in Patients with Relapsed or Refractory Advanced Solid Tumors (SITC 7641.pdf)

1.08 MBLisa GreavesEN 1 page
Document en en
Preview of Maltese
PDF file

Maltese (adjusol-trimethoprim-sulfa-liquide-article-34-referral-annex-i-ii-iii_mt.pdf)

434 KBEMAEN 32 pages
Annex I lists veterinary medicinal product details, including name, strength, pharmaceutical form, animal species, and route of administration, for various...
Preview of Celexa® (Citalopram Hydrobromide): Structural Formula, Warnings, and Description
PDF file

Celexa® (Citalopram Hydrobromide): Structural Formula, Warnings, and Description (020822s038s040021046s016s017lbl.pdf)

498 KBfda/cderEN 31 pages
Antidepressant Celexa (citalopram hydrobromide) carries an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults, requiring careful consideration of clinical need versus risk. Risk is reduced in adults aged 65 and older. Depression increases...
Preview of Applied Clinical Pharmacology (ACP) Program Overview
PDF file

Applied Clinical Pharmacology (ACP) Program Overview (PCL_MSc applied updated 2023-2024_0.pdf)

3.41 MBSarahEN 2 pages
Our program offers a highly customizable, course-based master's degree in Applied Clinical Pharmacology. Students complete interactive courses in clinical pharmacology, focusing on drug development, clinical trial design, and drug safety. Small class sizes facilitate...
Preview of Vitamin C Model
PDF file

Vitamin C Model (2005-v20n04-p237.pdf)

130 KBEN 8 pages
The dynamic flow model explains ascorbate's action in humans. It proposes a mechanism to compensate for the loss of vitamin C synthesis ability. This model links megadose effects with disease treatment.
Preview of https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017362s104lbl.pdf
PDF file

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017362s104lbl.pdf (017362s104lbl.pdf)

132 KBEN 7 pages
Progesterone injection USP, formulated in sesame oil for intramuscular use only, contains 50mg progesterone and 10% benzyl alcohol as a preservative. It promotes endometrial transformation and inhibits gonadotropin secretion to prevent ovulation.
Preview of Fabry disease prescribing info
PDF file

Fabry disease prescribing info (103979s5135lbl.pdf)

505 KBfda/cderEN 18 pages
Okay, the user wants a very brief description of the prescribing information for Fabrazyme in English, limited to 2-3 lines. Let me start by identifying the key points from the provided text. First, the drug is agalsidase beta, an injectable powder for IV use. Initial approval...

Popular Keywords

clinical patients pharmacology disease celexa buprenorphine pharmacokinetic prescribing associated approved pediatric safety extension label sodium adults severe model pharmacokinetics opioid including accurate development synercid administration treating infections linagliptin

Access our collection of Pharmacokinetics eBooks for free and learn more about Pharmacokinetics. These books contain exercises and tutorials to improve your practical skills, at all levels!

To find more books about Pharmacokinetics, you can use related keywords: Internationale Journale Pharmacokinetics Of Oral , PDF Modeling In Biopharmaceutics Pharmacokinetics, 15 Pharmacokinetics UT Pharm 2012 Indd , A Short Course In Pharmacokinetics, A Short Course In Pharmacokinetics University, Amikacin Pharmacokinetics Calculator, applied biopharmaceutics and pharmacokinetics, Applied Biopharmaceutics And Pharmacokinetics 6th

You can download PDF versions of the user's guide, manuals and ebooks about Pharmacokinetics, you can also find and download for free A free online manual (notices) with beginner and intermediate resources.